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1. Aim and Scope of Natural Product Sciences
Natural Product Sciences is the official publication of the Korean Society of Pharmacognosy which was launched in 1995. Natural Product Sciences
will primarily publish research papers on original work, either experimental or theoretical, that advance our understanding of natural product sciences,
including important questions of phytochemistry, chemistry, and bio- chemistry of natural resources. Timely reviews and commentaries on recent
progress in active areas of natural products will be also published.
 
2. Open Access Policy
All articles of Natural Product Sciences follow Open Access Policy and are distributed under the terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction
in any medium, provided the original work is properly cited.
 
3. Types of Manuscripts
Natural Products Sciences considers manuscripts for publication in the following types of papers: 
Research Articles: These are full-length research papers that describe new, significant, innovative, and original findings. Maximum length should
not generally exceed 24 typescript pages and should not contain more than 8 figures and/or tables. Research articles should contain Abstract, Key
words, Introduction, Experimental, Results and Discussion, Acknowledgments, and References.
Reviews provide a comprehensive summary of broadly-based topics of general interest to pharmaceutical scientists. Reviews should not generally
exceed 24 typescript pages. Reviews are generally submitted by invitation from the editorial board and encompass recent important scientific
discoveries.
 
4. How to Submit Manuscripts
The manuscript should be submitted as a file via "On-line Submission" section in our Web site (http://www.e-nps.or.kr/submission).
Prof. Jee H. Jung, Editor-in-Chief
College of Pharmacy, Pusan National University, Republic of Korea
Tel. +82-51-510-2803 Fax. +82-51-513-6754
E-mail: journal@e-nps.or.kr
 
5. Preparation of Manuscripts
(a) General Considerations. Manuscripts submitted to Natural Product Sciences should contain significant, unpublished, and original data not being
considered simultaneously for publication elsewhere. The manuscripts should be prepared in clear, concise English. It should be double-spaced on
A4 or letter size with 2.5 cm margin on all sides (text font size 12). The responsibility for all aspects of manuscript preparation depends on the
authors. Submit your text in DOC/DOCX format. Figures or tables can be attached within document or can be submitted as separate files. Locate
tables and figures after main text and list figure and table legends separately before the first table/figure. Insert special characters instead of
changing fonts when special characters (e.g. Greek letters) are required. Protocols used to generate animal and/or human experimental data should
be approved by an authorized Institutional Animal Care Committee and/or Human Experimentation Committee.
(b) Title Page. The title should be chosen carefully to provide information on the contents. The title should appear on a separate page and should be
followed by the author names and the institution name and address. The title, author name(s), and affiliations should all appear on their own
respective line of text. Place an asterisk after the name of the author to whom enquiries regarding the paper should be directed and include that
author’s telephone and fax numbers and e-mail address. Author affiliations must be footnoted using Arabic numbers (1, 2, 3, …).
(c) Abstract. It should be written to summarize purpose, method, result and conclusion of the research. The abstract should not exceed 200 words
for research articles and reviews. Compounds mentioned in the abstract, and given as specific Arabic numerals that are bolded in the text, should
also be accompanied in the abstract by the same bolded numerals. The abstract should be on a separate page and should be provided with the
bolded heading “Abstract”
(d) Keywords. Please provide 2~6 keywords that reflect the scientific content of your manuscript.
(e) Introduction. The manuscript should include an introduction under the bolded heading “Introduction” starting the purpose of the investigation
and relating manuscript to similar research.
(f) Experimental. To enable others to repeat the experiments, the procedures of experiments should be described in detail. Authors should describe
in detail for the novel experimental procedures, but known procedures from previous papers should be referred by literature citation. Animal and/or
human studies should declare that the study was performed under approval of protocol from the committee and the institution.
The presentation of specific details about instruments used, sources of specialized chemicals, and related experimental details should be
incorporated into the text of the Experimental Section as a paragraph headed General Experimental Procedures. The general order for inclusion
should be as follows: melting points; optical rotations; UV spectra; CD spectra; IR spectra; NMR spectra; mass spectra; and chromatographic and
other techniques.
In a separate paragraph, experimental biological material should be reported as authenticated if cultivated or from a natural habitat, and the
herbarium deposit site and voucher number should be recorded. The month and year when the organisms were collected should be stated, and it is
recommended that the exact collection location be provided using a GPS navigation tool. All microorganisms used experimentally should bear a
strain designation number and the culture collection in which they are deposited. The scientific name (genus, species, authority citation, and family)
should be presented when first mentioned in the body of the manuscript. Genus and species names should be italicized.
When physical and spectroscopic data are presented in the body of the manuscript, the following general style must be used (with the various
commonly used techniques presented in this same order): 
Actinofuranone C (1) - White powder. [α]20D : -10.5 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 231 (3.9), 282 (3.7) nm; IR (neat) νmax 3383, 2924, 1601,
1357, 970 cm-1; 1H and 13C NMR (CD3OD) see Table 1; HRFABMS m/z 363.2162 [M-H]− (calcd for C21H31O5, 363.2171).
Valinic acid (2) - 1H NMR (CD3OD, 400 MHz): δ 7.55 (1H, dd, J = 8.8, 2.0 Hz, H-1), 7.55 (1H, d, J = 2.0 Hz, H-2), 6.83 (1H, d, J = 8.8 Hz, H-5), 3.89
(3H, s, OCH3); 13C NMR (CD3OD, 100 MHz) δ 169.0 (C-7), 151.4 (C-4), 147.4 (C-3), 124.0 (C-6), 122.0 (C-1), 114.6 (C-5), 112.5 (C-2), 55.1
(OCH3); EI-MS m/z 168 [M]+.
(g) Abbreviations. Authors should write abbreviations without periods. Standard abbreviations should be used throughout the manuscript and
nonstandard abbreviations should be kept to a minimum and must be defined in the text following their first use.
(h) Results and Discussion. The “Results and Discussion” should be presented as a coherent whole section, in which the results are presented
concisely. The discussion should interpret the results and relate them to existing knowledge in the field in as clear and brief a fashion as possible.
Tables and figures should be designed to maximize the presentation and comprehension of the experimental data. For Full Articles of unusual length,
subheadings may be included within the “Results and Discussion” section. The major heading “Results and Discussion” should be bolded, with the
text starting on the line following. Subheadings are indented, followed by a period, and are a mix of uppercase and lowercase letters. The text follows
on the same line as the subheading. The results should be presented concisely with tables and figures. Authors should pay attention not to use same
data in more than one figure or in both a figure and a table. The detailed interpretation regarding results should be handled in discussion part.
However, it may be desirable to combine results and discussion in a single section.
(i) Acknowledgments. The Acknowledgment section should include credits [initial(s) and last name] for technical assistance, financial support, and
other appropriate recognition.
(j) References and Notes. References to the literature and all notes, regardless of their nature, should be numbered in order of appearance in the
manuscript and cited in the text with superscript numbers. Each reference may have its own citation number, or alternatively, references referring to
the same topic may be grouped under a common number using alphabetical subdesignations (e.g., 1a, 1b, 1c, etc.). The number of references and
notes should not generally exceed 25 for a research article. Use ISO standard abbreviated journal title. Journal abbreviations can be found in the ISI
Web of Knowledge website (http://admin-apps.webofknowledge.com/JCR/JCR?RQ=HOME). Each note should be assigned its own number.
References and notes should follow the format shown:
(1) Kuang, H.-X.; Yang, B.-Y.; Xia, Y.-G.; Feng, W.-S. Arch. Pharm. Res. 2008, 31, 1094-1097. 
(2) Lee, I. K.; Kim, K. H.; Lee, S. Y.; Choi, S. U.; Lee, K. R. Chem. Pharm. Bull. 2011, 59, 773-777.
(3) Field, L. D.; Sternhell, S.; Kalman, J. R. Organic Structures from Spectra; John Wiley & Sons: United Kingdom, 2013; p 93.
(4) Newman, D. J.; Cragg, G. M. In Natural Products as Drugs and Leads to Drugs: The Historical Perspective; Buss, A. D.; Butler, M. S. Ed; RSC
Publishing; United Kingdom, 2010, pp 3-27.
(5) Kaneko, I.; Minekura, H.; Takeuchi, Y.; Nakamura, T.; Haruyama, H. PCT Intl. 1994, 94-19481.
The author is responsible for the accuracy and completeness of all references. In particular, authors must cite all of the references from their own
work on a particular topic, such as all papers published or submitted on the constituents of a given organism under consideration. The author should
supply the Editor with copies of related manuscripts that are cited as “in press” or “submitted” for use by the editors and the reviewers in evaluating
the manuscript under consideration.
(k) Tables. Tables should be numbered consecutively with Arabic numerals. Use a brief title and a concise heading for each column. SI units are
preferred and data should be presented with significant figures. Footnote can be used and it should be given in lower case letter designations and
cited in the tables as italicized superscripts. All tables should be cited in the text.
(l) Illustrations. The quality of the illustration of original will determine the quality of the illustrations printed in author’s paper. Preferred formats for
graphics and artwork are TIFF (tagged image file format) and EPS (Encapsulated PostScript). Illustrations must fit a one- or two-column format on
the journal page however single column illustrations are preferred for the efficient use of journal space.
 Single (preferred) Double
Minimum Width  9 cm (3.5 in)
Maximum Width 8 cm (3.125 in) 16.5 cm (6.5 in)
Maximum Depth 23 cm (9 in) 23 cm (9 in)
For best results, submit illustrations in the actual size at which they should appear in the journal. Original illustrations which do not need to
be reduced to fit a single or double column will yield the best quality. Lettering should be no smaller than 4.5 points. (Helvetica type works well for
lettering.) Lines should not be thinner than 0.5 point. Lettering and lines should be of uniform density. If you must submit artwork that must be
reduced, use larger lettering and thicker lines so that, when reduced, the artwork meets the above-mentioned parameters. Avoid using complex
textures and shadings to achieve a three-dimensional effect. To show a pattern, choose a simple cross-hatch design. 
Color. All color figures will be reproduced in full color in the online edition of the journal at no cost to the authors. Authors are required to pay the cost
of reproducing color figures in print. Authors are encouraged to submit color illustrations that highlight the text and convey essential scientific
information. For best reproduction, bright, clear colors should be used.
(m) Chemical Structures. Structures should be produced with the use of a drawing program such as ChemDraw. Structure drawing preferences
(preset in the ACS Stylesheet in ChemDraw) are as follows:
1. As drawing settings select :
 
chain angle 120º
bond spacing 18% of width
fixed length 14.4 pt (0.508 cm, 0.2 in.)
bold width 2.0 pt (0.071 cm, 0.0278 in.)
line width 0.6 pt (0.021 cm, 0.0084 in.)
margin width 1.6 pt (0.056 cm, 0.0222 in.)
hash spacing 2.5 pt (0.088 cm, 0.0347 in.)
  
2. As text settings select:
 
font Arial/Helvetica
size 10 pt
  
3. Under the preferences choose:
 
units points
tolerances 5 pixels
  
4. Under page setup choose:
 
Paper A4 or Letter
Scale 100%
  
5. Using the ChemDraw ruler or appropriate margin settings, create structure blocks, schemes, and equations having maximum widths of 11.3 cm
(one-column format) or 23.6 cm (two-column format). Note: if the foregoing preferences are selected as cm values, the ChemDraw ruler is calibrated
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6. Embolden compound numbers, but not atom labels or captions.
(n) Nomenclature. It is the responsibility of the authors to provide correct nomenclature. All nomenclature must be consistent and unambiguous and
should conform to current American usage. Insofar as possible, authors should use systematic names similar to those used by Chemical Abstracts
Service, the International Union of Pure and Applied Chemistry, and the International Union of Biochemistry and Molecular Biology.
The chemical names for drugs should be used. If the terminology is unwieldy, nonproprietary names of drugs may be used throughout the manuscript
after the first mention and identification. Formally adopted nonproprietary names listed in United States Adopted Names (USAN) should be used. In
cases in which a name has not been assigned by USAN, the International Nonproprietary Names (INN), approved by the World Health Organization,
should be used. Trade names and laboratory codes should not be used except as additional information.
 
6. Proofs and Reprint
Proofs are sent to the author who submitted the papers. Authors are directed via email to download proofs from a secure FTP site unless authors
request otherwise. Proofs should be verified against the manuscript and appropriate corrections made. Substantial changes in a manuscript after
type has been set require editorial approval and in some cases may be cause for re-reviewing. An order form for reprints will be sent with the proofs.
Please return the reprint order form, along with a purchase order or check, reprints will be shipped within 2 weeks after the printed journal date.
 
7. Corrections
If errors of consequence are found in the published paper, a correction of the error should be sent by the author to the Editor for publication in the
journal’s Errata Section.
 
8. Copyright Transfer Agreements (CTA)
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Flavestin K, An Isoprenylated Stilbene from the Leaves 
of Macaranga recurvata Gage
Tjitjik Srie Tjahjandarie1,*, Mulyadi Tanjung1, Ratih Dewi Saputri1, Puja Bintu Nadar1, 
Muhammad Fajar Aldin1, EvaMarliana2 and Anton Permadi3
1Natural Products Chemistry Research Group, Organic Chemistry Division, Department of Chemistry, 
Faculty of Science and Technology, Universitas Airlangga, Surabaya, Indonesia
2Department of Chemistry, Faculty of Mathematics and Natural Science, Universitas Mulawarman, Samarinda, Indonesia
3Department of Management, Sekolah Tinggi Ilmu Ekonomi Muara Teweh, North Barito, Muara Teweh, Indonesia
Abstract − A new isoprenylated stilbene, flavestinK (1) together with two known isoprenylated stilbenes,
flavestin B (2), flavestin G (3), and two isoprenilated flavanones, 4-O-methyl-8-isoprenylnaringenin (4) and 8-
isoprenyl-5,7-dihydroxyflavanone (5) were isolated from the leaves of Macaranga recurvata Gage. All of the
structures have been determined based on HRESIMS, 1D and 2D NMR spectral data. All of the isolated
compounds were evaluated for their cytotoxicity against three human cancer cells (HeLa, T47D and WiDr).
Compound 1 showed higher activity than doxorubicin against HeLa cells with IC50 value of 13.1 µg/mL.
Keywords − Flavestin K, Stilbene, Macaranga recurvata, Cytotoxicity
Introduction
Macaranga recurvata Gage (Euphorbiaceae), locally
known as ‘Mahang merah’ is one pioneer plant and found
endemic in Kalimantan Island, Indonesia. The genus
Macaranga have been showed a number of phenolic
compounds, predominantly flavonoids and stilbenes with
terpenylated side chain (isoprenyl, geranyl and farnesyl)
in aromatic ring.1-4 Based on previously report, two
isoprenylated dihydroflavonols, macarecurvatins A and B
from the leaves of M. recurvata showed cytotoxicities
against murine leukemia.5 Isoprenylation of flavonoids
and stilbenes seems to be a key factor to enhance their
cytotoxicity. 
In this research paper, we desiderate to report the
isolation of a new isoprenylated stilbene, flavestin K (1)
along with four known compounds, flavestin B (2),
flavestin G (3), 4′-O-methyl-8-isoprenylnaringenin (4)
and 8-isoprenyl-5,7-dihydroxyflavanone (5) from the
leaves of M. recurvata (Fig. 1). The cytotoxic activities of
compounds 1-5 against three human cancer cells (HeLa,
T47D and WiDr) are also reported.
Experimental
General experimental procedures – 1D NMR (1H
and 13C), 2D NMR (HMQC and HMBC) spectra were
recorded with a JEOL JNM-ECA 400 FT NMR spectro-
meter operating at 400 MHz usingdeuterated solvent
(peaks: δH 2.04 and δC 29.8 for acetone-d6 as reference
standard). High resolution mass spectra were measured on
an ESI-TOF Waters LCT Premier X Emass spectrometer.
All of compounds were dissolved in methanol and were
measured by UV spectrophotometer Shimadzu 1900. The
functional group of compounds in KBr were measured by
IR Tracer-100 Shimadzu FT IR spectrophotometer. Column
chromatography (CC) was performed using Si gel 60 G
and centrifugal planar chromatography (CPC) was per-
formed using Si gel 60 PF254. TLC analysis was per-
formed using on pre-coated Si gel 60 GF 254 0.25 mm
thickness plates. 
Plant materials – The leaves of M. recurvata were
collected from Muara Teweh, North Barito Districts, East
Kalimantan, Indonesia on Feb. 2018, and identified by
senior botanist Mr. Ismail Rachman from the Herbarium
Bogoriense, Center of Biological Research and Develop-
ment, National Institute of Science, Bogor, Indonesia.
Extraction and isolation – The air-dried and powdered
leaves of M. recurvata (3.5 kg) were extracted with
MeOH (2 × 15 L) at room temperature for two days, and
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after evaporation gave the viscous concentrated of MeOH
extract (210 g). The suspended solids was redissolved in
MeOH-H2O (9:1) and then partitioned with C6H14 (45 g)
and EtOAc (22 g), successively. 
The EtOAc extract (20 g) was further fractionated by
column chromatography on silica gel (800 g) eluted with
C6H14-EtOAc (from 9:1 to 1:1) by gradient elutionto give
five major fractions A-E. Fraction B (2.10 g) was separated
by sephadex LH-20 eluted with MeOH gave subfractions
B1-B2. Subfraction B2 was purified by centrifugal planar
chromatography using C6H14-CHCl3 (from 7:3 to 3:7) to
yield compounds 4 (30 mg), and 5 (19 mg). Fraction C
(2.8 g) was subjected to sephadex LH-20 and eluted with
MeOH gave three subfractions C1-C3. Subfraction C1 was
purified by CPC using C6H14-EtOAc (from 9:1 to 4:1)
gave compound 2 (40 mg) and purification of subfraction
C2 by the same methods using n-hexane-diisopropylether
(from 1:1 to 1:4) to yield compounds 1 (5 mg), and 3 (21 mg).
Flavestin K (1) − Yellow solid, UV (MeOH) λmax nm
(log ε): 212 (4.49), and 293 (4.26). IR (KBr) νcm−1: 3400,
1604, 1521, 1438 and 1033. 1H and 13C NMR see Table 1.
HRESIMS: m/z [M-H]− calcd. for C19H21O3 297.1491,
found 297.1489.
Flavestin B (2) − Amorphous powder, UV (MeOH)
λmax nm (log ε) : 215 (4.39), and 303 (4.10). IR (KBr)
νcm−1: 3368, 1608, 1530, 1463 and 1028. HRESIMS: m/z
[M-H]− calcd. for C19H19O2 279.1523, found 279.1519.
The 1H and 13C NMR spectral data were compared and
consistent with the published data.6
Flavestin G (3) − Amorphous powder, UV (MeOH)
λmax nm (log ε): 214 (4.42), and 295 (4.17). IR (KBr)
νcm−1: 3340, 1602, 1548, 1459 and 1033. HRESIMS: m/z
[M-H]− calcd. for C19H19O2 279.1489, found 279.1480.
The 1H and 13C NMR spectral data were compared and
consistent with the published data.6
4′-O-Methyl-8-isoprenylnaringenin (4) − White solid,
m.p. 169 - 170 oC. UV (MeOH) λmax nm (log ε): 214
(4.46), and 293 (4.67). IR (KBr) νcm−1: 3425, 1640, 1515,
1448 and 1170. HRESIMS: m/z [M-H]− calcd. for
C21H21O5 353.1457, found 353,1452. The 
1H and 13C NMR
spectral data were compared and consistent with the
published data.7
8-Isoprenyl-5,7-dihydroxyflavanone (5) − White solid,
m.p. 165 - 167 oC. UV (MeOH) λmax nm (log ε) : 224
(4.49), and 294 (4.73). IR (KBr) νcm−1: 3418, 1638, 1520,
1446 and 1168. HRESIMS: m/z [M-H]− calcd. for
C20H19O4 323.1362, found 323.1365. The 
1H and 13C NMR
spectral data were compared and consistent with published
data.8
Cytotoxic activity − Compounds 1 - 5 were appraised
for their cytotoxicity toward HeLa (human cervical carci-
noma), T47D (human breast cancer), and WiDr (human
colon carcinoma) according to the MTT method as well
as doxorubicin as the positive control.9-12 Briefly, before
the compounds were added, cells were cultured in 96-well
at a density of 3 × 104 cells/well and incubated at 37 oC
for 24 h. Compounds 1 - 5 with variations in concentration
(100, 30, 10, 3, 1, 0.3, and 0.1 μg/mL) with triplicate were
Fig. 1. Stilbenes and flavonoids 1 - 5 isolated from the leaves of M. recurvata.
246 Natural Product Sciences
added to each well and incubated at 37 ºC for 48 h. After
incubation, it was added MTT and let for 4 h, and the
inhibition of cells by each of compounds 1 - 5 were
recorded with microplate reader spectrophotometer at λ
570 nm. The IC50 values of all compounds were calculated
by regression analysis.
Result and Discussion
Flavestin K (1) obtained as yellow solid, and the
chemical formula C19H22O3 was deduced by HRESIMS
spectra with ion peak [M-H]− at m/z 297.1489 (calcd. for
297.1491). The UV spectrum showed two maximum
absorption at λmax (log ε) 212 (4.49), and 293 (4.26) nm
characteristic for a stilbene chromophore.13 The IR spectrum
displayed absorption band for hydroxyl (3400 cm−1), and
aromatic ring (1521 - 1438 cm−1), respectively. The 1H
NMR spectrum of compound 1 (Table 1) exhibited two
doublets (J = 16.1 Hz) at δH 7.52 (H-α) and δH 6.98 (H-β)
provided the evidence for a trans 1,2-disubstituted ethene
connecting with two aromatic rings, revealed that com-
pound 1 was (E)-stilbene.14 The existence of meta-coupling
doublets (J = 2.4 Hz) at δH 6.35 (H-4) and δH 6.69 (H-6) is
characteristic for a 1,2,3,5-tetrasubstituted benzene. The
presence of three multiplet signals at δH 7.57 (H-2'/H-6'),
δH 7.34 (H-3'/H-5') and δH 7.24 (H-4') is consistent for a
monosubstituted benzene. 1H NMR spectrum of 1 also
disclosed information two phenolic hydroxyl groups at δH
8.19 (3-OH), and δH 7.99 (5-OH). The proton signals for a
2-methylbutan-2-ol unit were observed at δH 3.58 (3''-
OH), 2.83 (H2-1''), 1.66 (H2-2'') and 1.25 (H3-4'' and H3-
5'') in the 1H NMR spectrum. Sixteen carbon signals were
observed in 13C NMR spectrum. The carbon NMR signals
including two oxyaryl carbon signals (δC 156.9 and δC
156.7) recommended that compound 1 has a structure of
pinosylvin (E-3,5-dihydroxystilbene) bearing a 2-methyl-
butan-2-ol group.15 Location of a 2-methylbutyl-2-ol group
in pinosylvin structure was established by 2D NMR
spectra (HMQC and HMBC) (Fig. 2). The H-α proton
Table 1. NMR data of flavestin K (1)
No. C δH (mult, J in Hz) δC HMBC (H C)
1 - 138.8 -
2 -  120.2 -
3 -  156.9 -
4 6.35 (d, 2.4) 103.2 C-2; C-3; C-6
5 - 156.7
6 6.69 (d, 2.4) 104.4 C-α; C-2; C-4; C-5
α 7.52 (d, 16.1) 127.5 C-2; C-6; C-1'
β 6.98 (d, 16.1) 130.2 C-1; C-2'/6'
1' - 138.2 -
2'/6' 7.57 (m) 127.3 C-β; C-4'
3'/5' 7.34 (m) 129.5 C-1'; C-3'/5'
4' 7.24 (m) 128.2 C-3'/5'
1" 2.83 (m) 20.7 C-1; C-2; C-3; C-2"; C-3"
2" 1.66 (m) 45.0 C-2; C-1"; C-3"; C-4"; C-5"
3" - 70.5 -
4" 1.25 (s) 29.9 C-2"; C-3"; C-5"
5" 1.25 (s) 29.9 C-2"; C-3"; C-4"
3-OH 8.19 (s) - C-2; C-3; C-4
5-OH 7.99 (s) - C-5; C-6
3"-OH 3.58 (s) - C-2"; C-3"; C-4"; C-5"
Fig. 2. Selected HMBC correlations for flavestin K (1).
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(δH 7.52) of the ethene group correlated with a methine
carbon at δC 104.4 (C-6) and two quaternary carbons at δC
120.2 (C-2) and at δC 138.2 (C-1′) in the HMBC spectrum
of 1. The HMBC correlations of the methylene proton
signal at δH 2.83 (H-1'') to δC 138.8 (C-1), 120.2 (C-2),
156.9 (C-3), 45.0 (C-2''), and 70.5 (C-3'') indicated that a
2-methylbutyl-2-ol chain was located at C-2. The presence
of 2-methylbutan-2-ol chain was further supported by
HMBC correlations between the hydroxyl proton signal at
δH 3.58 (3''-OH) and the carbon signals at δC 29.9 (C-4''
and C-5''), 45.0 (C-2'') and 70.5 (C-3''). The structure of
compound 1 was thus identified as 2-(3-hydroxy-3-
methylbutyl)-pinosylvin. We designated the compound 1
as flavestin K.
The cytotoxicity activityof compounds 1 - 5 were
appraised towards HeLa (human cervical carcinoma), T47D
(human breast cancer), and WiDr (human colon carcinoma)
by MTT method as well as doxorubicin (positive control).16
Isoprenylated stilbenes (1, 2 and 3) more active than
isoprenylated flavonoids (4 and 5) (Table 2). Compound 1
exhibited higher activity than doxorubicin against HeLa
with IC50 value of 13.1 μg/mL. However, compounds 4 - 5
were inactive against HeLa, T47D, and WiDr cells.
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Table 2. Cytotoxicity of compounds 1 - 5 of M. recurvata
Compounds IC50 (µg/mL)
HeLa T47D WiDr
Flavestin K (1) 13.10 ± 0.87 51.12 ± 1.21 46.41 ± 1.25
Flavestin B (2) 54.80 ± 1.15 >100 >100
Flavestin G (3) 55.84 ± 2.68 73.04 ± 2.71 70.35 ± 2.58
4'-O-Methyl-8-isoprenylnaringenin (4) >100 >100 >100
8-Isoprenyl-5,7-dihydroxyflavanone (5) >100 >100 >100
Doxorubicin 46.11 ± 0.45 23.18 ± 0.45 12.44 ± 0.45
